**Question:** Aniridia is associated with:

Aniridia is a rare genetic disorder characterized by the absence or underdevelopment of the iris, leading to varying degrees of visual impairment and potential blindness. The correct answer is:

**Correct Answer:** A. Wilms Tumor Predisposition Syndrome (Wilms Tumor 1 Gene - WT1)

**Core Concept:** Aniridia is a clinical manifestation linked to specific genetic mutations. In this case, it is associated with mutations in the Wilms Tumor 1 (WT1) gene, which is located on chromosome 11p13. The WT1 gene plays a crucial role in embryonic development, particularly in the formation of the kidney, urinary tract, and eyes.

**Why the Correct Answer is Right:** Aniridia is caused by mutations in the WT1 gene, resulting in abnormal development of the iris, kidney, and other structures. In the context of the question, the most relevant association is with Wilms Tumor Predisposition Syndrome (Wilms Tumor 1 Gene - WT1), as it explains the genetic basis of aniridia and the predisposition to develop other disorders, such as Wilms' tumor, in affected individuals.

**Why Each Wrong Option is Incorrect:**

B. Gorham-Stout Syndrome: This is a rare disorder characterized by progressive bone resorption and replacement with fibrous connective tissue. It is unrelated to aniridia and carries a different set of genetic mutations.

C. Diabetes Insipidus: This is a condition characterized by excessive urine production due to impaired renal response to antidiuretic hormone (ADH). Aniridia is unrelated to diabetes insipidus and does not explain the genetic basis for the absent or underdeveloped iris.

D. Cystinosis: This is a rare genetic disorder characterized by the accumulation of the amino acid cystine in various tissues due to impaired renal cystine excretion. Aniridia is unrelated to cystinosis and does not explain the genetic basis for the absent or underdeveloped iris.

**Clinical Pearl:** Aniridia is a rare genetic disorder with a distinct genetic cause and clinical features. Understanding the genetic basis of aniridia, specifically the WT1 gene mutation, is essential for recognizing potential complications and providing appropriate management for affected individuals. Genetic counseling and early detection of associated conditions like Wilms' tumor are crucial aspects of care for patients with aniridia.